Therma Bright (TSE:THRM) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Therma Bright Inc. celebrates the successful initial clinical trial results of the PREVA™ ischemic stroke device, developed by its investment partner Inretio, which were presented at the BRAIN Conference 2024. The device promises to revolutionize stroke care by improving patient recovery outcomes, marking a significant milestone for Inretio’s clinical program.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.